Friedman Cindy R, Morfino Robert C, Ernst Ezra T
Emerg Infect Dis. 2025 May;31(13):35-38. doi: 10.3201/eid3113.241407.
Airport-based pathogen monitoring is a critical tool that can contribute to early detection and characterization of existing and new pathogen threats. A novel public-private partnership between an airport spa group, a biotech company, and the Centers for Disease Control and Prevention was instrumental in establishing a multimodal pathogen genomic surveillance program at US international airports. That public-private partnership addressed critical challenges that neither party could overcome independently, resulting in the development and deployment of a scalable, flexible early warning system for pathogen detection and public health monitoring.
基于机场的病原体监测是一项关键工具，有助于对现有和新出现的病原体威胁进行早期检测和特征描述。一家机场水疗集团、一家生物技术公司和疾病控制与预防中心之间建立的新型公私合作伙伴关系，对于在美国国际机场建立多模式病原体基因组监测计划起到了关键作用。这种公私合作解决了任何一方都无法单独克服的重大挑战，从而开发并部署了一个可扩展、灵活的病原体检测和公共卫生监测预警系统。
